Literature DB >> 7489915

Characterization and overexpression of the gene encoding Staphylococcus aureus DNA polymerase III.

D F Pacitti1, M H Barnes, D H Li, N C Brown.   

Abstract

The polC gene specifying DNA polymerase III (PolIII) of Staphylococcus aureus (Sa), was cloned with a novel strategy and found to contain a 4305-bp open reading frame (ORF) encoding a polypeptide of approx. 162 kDa. The 1435-codon ORF was engineered into an Escherichia coli (Ec) expression plasmid under the control of the lac promoter and its repressor. Derepression of Ec transformants carrying the recombinant (re-) vector generated high-level synthesis of active re-Sa PolIII. The re-PolIII was purified to > 98% homogeneity and was shown by N-terminal amino acid sequence analysis to be the bona fide product of the Sa polC ORF. The physical and catalytic properties of re-Sa PolIII and its responsiveness to inhibitors of the HPUra type were generally similar to those of Bacillus subtilis (Bs) PolIII. Comparative analysis of the primary structures of Sa PolIII, Bs PolIII and Mycoplasma pulmonis PolIII indicated strong conservation of essential catalytic domains and a novel zinc-finger motif. Comparison of the primary structures of Ec PolIII and these three Gram+ enzymes revealed a region of novel homology and reinforced the likelihood of a specific evolutionary relationship between PolIII of Gram+ and Gram- eubacteria. The polC gene mapped between omega 1074 [Tn551] and recA/ngr on the Sa NCTC 8325 genome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489915     DOI: 10.1016/0378-1119(95)00377-i

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Mutational analysis of the 3'-->5' proofreading exonuclease of Escherichia coli DNA polymerase III.

Authors:  S A Taft-Benz; R M Schaaper
Journal:  Nucleic Acids Res       Date:  1998-09-01       Impact factor: 16.971

2.  Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzyme.

Authors:  Alexander Kuhl; Niels Svenstrup; Christoph Ladel; Michael Otteneder; Annegret Binas; Guido Schiffer; Michael Brands; Thomas Lampe; Karl Ziegelbauer; Helga Rübsamen-Waigmann; Dieter Haebich; Kerstin Ehlert
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.

Authors:  P M Tarantino; C Zhi; G E Wright; N C Brown
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

4.  In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.

Authors:  J S Daly; T J Giehl; N C Brown; C Zhi; G E Wright; R T Ellison
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

5.  Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile.

Authors:  Erika van Eijk; Ilse M Boekhoud; Ed J Kuijper; Ingrid M J G Bos-Sanders; George Wright; Wiep Klaas Smits
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

6.  DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics.

Authors:  Timothy J Opperman; Steven M Kwasny; Jessica Bo Li; Mark A Lewis; Daniel Aiello; John D Williams; Norton P Peet; Donald T Moir; Terry L Bowlin; Eric C Long
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Clostridium difficile DNA polymerase IIIC: basis for activity of antibacterial compounds.

Authors:  Andrea Torti; Andrea Lossani; Lida Savi; Federico Focher; George Edward Wright; Neal Curtis Brown; Wei-Chu Xu
Journal:  Curr Enzym Inhib       Date:  2011-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.